Skip to main content
Clinical Trials/NCT02216162
NCT02216162CompletedNot Applicable

PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program Including a Regular Physical Training, a Medical and Nutritional Follow-up, on Adjuvant Hormonal Treatment Compliance in Breast Cancer Patients Over 70 Years.

Hospices Civils de Lyon2 sites in 1 country12 target enrollmentStarted: April 11, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
12
Locations
2
Primary Endpoint
Compliance of an adjuvant hormonal therapy

Study Overview

Brief Summary

PROACTIVE randomized study to evaluate the impact of a multidimensional geriatric intervention on treatment compliance, measured regularly by blood dosing of drug metabolites.

Patients in the intervention group will be proposed:

  • A regular geriatric follow up including an attentive screening of joint symptoms and functionality,
  • An adapted treatment of join pain,
  • Weekly sessions of adapted physical activity (Taï Chi),
  • And a systematic correction of vitamin D deficits.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
70 Years to — (Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 70 years old
  • Non metastatic breast cancer, with or without node metastases
  • Hormone Receptor (HR) positive breast cancer patients
  • Women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery or radiotherapy
  • Introduce an hormonal therapy during 5 years
  • Life expectancy > 6 months (at the discretion of the investigator)
  • Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research
  • Patient must be available for follow-up
  • Having given written informed consent prior to any procedure related to the study

Exclusion Criteria

  • No other primary malignant tumor < 5-years old except cured in situ cancer of the cervix, in situ urothelial cancer, or basocellular cancer
  • Patient with an experimental treatment in the 30 days prior to the enrollment
  • Evidence of metastatic disease
  • Not under any administrative or legal supervision

Arms & Interventions

A: Interventional adapted physical activity + enhanced geriatr

Experimental

Geriatric (functionality, gait, nutrition) follow-up, biological tests, anti-aromatase agents blood dosing, clinical assessment. Weekly Taï-Chi exercises.

Intervention: Arm A: adapted physical activity + enhanced geriatric follow-up (Other)

Arm B: control

Other

Clinical follow-up according to the Guidelines, annual geriatric and nutritional assessment

Intervention: No intervention (Other)

Outcomes

Primary Outcomes

Compliance of an adjuvant hormonal therapy

Time Frame: 3 years of follow up

Compliance rate is defined as the rate of blood samplings of anti-hormone metabolites in the therapeutic range, within the 7 blood samplings distributed in the 3 years of follow-up

Secondary Outcomes

  • Activities of daily living, functional walking capacity and changes in balance(3 years of follow up)
  • Quality of life(3 years of follow up)
  • Intensity and duration of musculoskeletal adverse events(3 years of follow up)
  • Nutritional status(3 years of follow up)
  • Analgesics consumption(3 years of follow up)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials